Medical Fair Asia 2026 於新加坡 Marina Bay Sands 圓滿落幕。本屆展會匯聚超過 1,000 家參展商及 14,000 名以上醫療產業專業人士，為亞洲重要的醫療與 MedTech 國際交流平台。
世延生醫此次展示 EarlyFound® MMP-1 ELISA Kit 與 EarlyFound® MMP-1 Rapid Strip Test，與來自新加坡及東南亞各地的醫療專業人士、經銷商及產業夥伴進行交流，很高興我們的非侵入式唾液口腔癌檢測技術獲得許多來賓的關注與正面回饋。
展會期間，我們亦榮幸迎來 新竹科學園區管理局倪茂榮副局長蒞臨世延攤位交流與指導，給予團隊許多鼓勵。此次竹科管理局亦赴新加坡推動臺星生醫產業及商務交流，積極協助台灣生醫企業鏈結國際市場。
此外，世延團隊也拜訪新加坡 Changi General Hospital（CGH）樟宜綜合醫院，與 Office of Innovation 團隊就醫療創新、臨床應用及未來合作機會進行交流。CGH Office of Innovation 長期推動創新技術的共同開發、轉譯與商業化，期待未來雙方能有更多合作的可能。
世延生醫將持續拓展國際市場，期待與全球 醫療機構、經銷代理商及技術合作夥伴建立更多連結，共同探索產品市場導入、臨床應用與技術合作的機會。
S&T BioMed at Medical Fair Asia 2026 | Expanding Connections Across Southeast AsiaMedical Fair Asia 2026 successfully concluded at Marina Bay Sands, Singapore, bringing together more than 1,000 exhibitors and over 14,000 healthcare trade visitors.
At the exhibition, S&T BioMed showcased the EarlyFound® MMP-1 ELISA Kit and EarlyFound® MMP-1 Rapid Strip Test. We were pleased to connect with healthcare professionals, distributors, and industry partners from Singapore and across Southeast Asia, and to receive encouraging interest and feedback on our non-invasive saliva-based oral cancer detection solutions.
We were also honored to welcome Mr. Mao-Jung Ni, Deputy Director General of the Hsinchu Science Park Bureau, NSTC, to our booth for交流 and encouragement. The Hsinchu Science Park Bureau was also in Singapore to promote Taiwan–Singapore biomedical industry and business connections.
During our stay, the S&T BioMed team also visited Changi General Hospital (CGH) and exchanged perspectives with its Office of Innovation on healthcare innovation, clinical applications, and opportunities for future collaboration.
We look forward to building partnerships with healthcare institutions, distributors, agents, and technology partners worldwide, exploring opportunities in market access, clinical applications, product distribution, and technology collaboration.
